Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

Background The CLARITY and CLARITY Extension studies demonstrated that treatment of relapsing–remitting multiple sclerosis (RRMS) with cladribine tablets (CT) results in significant clinical improvements, compared with placebo. This paper presents the key magnetic resonance imaging (MRI) findings fr...

Full description

Bibliographic Details

Published in:	Therapeutic advances in neurological disorders Vol. 11; p. 1756285617753365
Main Authors:	Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
Format:	Journal Article
Language:	English
Published:	London, England SAGE Publications 01.01.2018 SAGE PUBLICATIONS, INC SAGE Publishing
Series:	Therapeutic Advances in Neurological Disorders
Subjects:	Life Sciences Magnetic resonance imaging Multiple sclerosis NMR Nuclear magnetic resonance Original Research relapsing–remitting multiple sclerosis magnetic resonance imaging cladribine extension study relapsing-remitting multiple sclerosis
ISSN:	1756-2864, 1756-2856, 1756-2864
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!